Search for a clinical trial
Other search option(s)
7 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Terminated trial = 
; Funded by an IRDiRC member = 
; Study involving ERN members in at least two Member States = 
National clinical trial(s)
FRANCE
HAUTS-DE-FRANCE
ADDRESS: NOT PROVIDED - FR
A Multi-center, Open-Label, Adaptive, Randomized Study of Palifosfamide-tris, a Novel DNA Crosslinker, in Combination with Carboplatin and Etoposide (PaCE) Chemotherapy versus Carboplatin and Etoposide (CE) Alone in Chemotherapy Naďve Patients with Extensive-Stage Small Cell Lung Cancer. The MATISSE Study - FR
Institution: Information not provided - FR
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
A Multi-center, Open-Label, Adaptive, Randomized Study of Palifosfamide-tris, a Novel DNA Crosslinker, in Combination with Carboplatin and Etoposide (PaCE) Chemotherapy versus Carboplatin and Etoposide (CE) Alone in Chemotherapy Naďve Patients with Extensive-Stage Small Cell Lung Cancer. The MATISSE Study - DE
Institution: Information not provided - DE
GERMANY
Nordrhein-Westfalen
KÖLN
PICASSO III: A Phase III multicenter, international, randomized, double-blind, placebo-controlled study of Doxorubicin plus Palifosfamide-tris versus Doxorubicin plus Placebo in patients with front-line metastatic Soft Tissue Sarcoma - DE - Completed
Universitätsklinikum Köln
Klinik I für Innere Medizin
SPAIN
Madrid
MAJADAHONDA
PICASSO III: A Phase III Multicenter, International, Randomized, Double-blind, Placebo-controlled Study of Doxorubicin Plus Palifosfamide-tris vs. Doxorubicin Plus Placebo in Patients With Front-line Metastatic Soft Tissue Sarcoma - ES (completed)
Hospital Universitario Puerta de Hierro - Majadahonda
Servicio de Oncología Médica
UNITED KINGDOM
Greater Manchester
ADDRESS: NOT PROVIDED - UK
PICASSO III: A Phase III multicenter, international, randomized, double-blind, placebo-controlled study of doxorubicin plus palifosfamide-tris vs. doxorubicin plus placebo in patients with front-line metastatic soft tissue sarcoma - UK
Institution: Information not provided - UK
UNITED KINGDOM
Greater Manchester
ADDRESS: NOT PROVIDED - UK
A Multi-center, Open-Label, Adaptive, Randomized Study of Palifosfamide-tris, a Novel DNA Crosslinker, in Combination with Carboplatin and Etoposide (PaCE) Chemotherapy versus Carboplatin and Etoposide (CE) Alone in Chemotherapy Naďve Patients with Extensive-Stage Small Cell Lung Cancer - GB
Institution: Information not provided - UK
UNITED STATES
Massachusetts
BOSTON